Denali Therapeutics Inc.

DNLI · Healthcare

$23.27

Markedsværdi: 3.72B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Denali Therapeutics Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

MT Newswires4. sep. 2026, 21.12

Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing

MT Newswires25. aug. 2026, 11.55

B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating

Zacks20. aug. 2026, 16.20

DNLI Stock Gains 33.1% in Three Months: Buy, Sell or Hold the Stock?

Zacks20. aug. 2026, 14.12

Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?